We install everything most clinics are missing: world-class biologics, the protocols that make them work, and an AI patient acquisition system that fills the schedule — without you hiring a sales team or building it from scratch.
Complimentary · qualified clinics · 60–90 min · with senior strategist
Patients want regenerative outcomes. Most clinics still can't offer them. The gap between what patients are searching for and what practices actually deliver has never been wider — or more profitable to close.
The gap is the business. Patients are actively searching for regenerative options for joints, hair, skin, performance, and longevity. A small fraction of clinics are positioned to capture them. That asymmetry is what XLR8 installs against.
The federal FDA 361 HCT/P pathway plus active state frameworks (Utah, Florida HB 1617) have opened compliant lanes for clinics in nearly every vertical.
Search interest for regenerative treatments outpaces traditional services. The clinics ranking and converting are the ones actually offering it.
Done-for-you AI campaigns, funnels, and follow-up sequences turn marketing into a system — but only if you have an offer worth marketing.
Once a clinic in a market owns the regenerative position, it's expensive to dislodge. Speed of installation is the unfair advantage.
A real business-in-a-box: the products, the methods, and the patient pipeline. Each pillar reinforces the others. You don't pick one — they install together.
Flowable allograft HCT/P biologics backed by 30+ years of research and 900+ peer-reviewed studies. We secure clinic-grade sourcing and select the right products for your vertical.
Multi-modality treatment protocols built by world leaders in regenerative medicine. The difference between average outcomes and the kind of results patients tell their friends about.
The complete pipeline: paid campaigns, diagnostic front-end offers, high-converting funnels, AI nurture sequences, and follow-up automation. You don't hire a marketing team — you inherit ours.
Products × Protocols × AI Marketing = A category of one in your local market.
Audit My ClinicEvery consultant on the internet is selling an "AI audit." Most have never installed a category-defining offer inside a real medical practice. They run better ads for the same commoditized services your competitor across town also offers. That isn't a strategy — that's a price war with extra steps.
The clinics scaling past $50K/mo in new revenue aren't winning because their funnels are smarter. They're winning because they sell something the practice down the street simply can't: clinically backed regenerative outcomes, delivered through tested protocols, marketed through a system that actually fills the schedule.
That's what XLR8 Medical installs. The products are real. The protocols are clinical. And the AI marketing only works because there's a genuine offer behind it.
"Anyone can run ads. We rebuild the offer the ads point at — then we run the ads, too."
No mystery, no consulting theater. Every stage has a deliverable, a timeline, and an exit point if it stops being a fit.
60–90 min review of your clinic, vertical, and revenue opportunity.
Written plan: products, protocols, channels, projections.
Biologics sourcing, staff training, marketing build-out.
Campaigns live, first patients booked, protocols delivered.
Ongoing optimization to $50K/mo and beyond.
The audit is structured, not improvised. The same framework we've used with 100+ clinic installations. You leave with a written revenue map — yours to keep, whether we work together or not.
Which specific HCT/P biologics are clinically and commercially right for your practice — orthopedic injectables, hair formulations, aesthetic preparations, or functional medicine applications.
We don't sell treatments cold. We design a vertical-specific diagnostic offer (Joint Health Eval, Hair Wellness Assessment, Biological Age Test) that earns the treatment conversation.
Which Master Healer protocols your team can deliver, what training is required, and how to layer treatments so patient outcomes compound rather than plateau.
Where your qualified patients actually live online — paid social, paid search, organic, referral — and which channels will work in your specific market without burning cash.
Most clinics lose 60–80% of leads to slow follow-up. We review your intake speed, nurture sequences, and the AI automations that should sit underneath all of it.
A math-backed projection: patient volume × procedure mix × average ticket × membership upsell. Floor, realistic, upside — and the operating assumptions behind each.
Your audit includes a written review of your specific jurisdiction so you know exactly what's legal, what's required, and what's coming.
Minimally manipulated biologics for homologous use — the core federal compliance pathway clinics operate within.
The first formal state-level framework authorizing placental tissue therapies — now a model being adopted elsewhere.
Authorizes licensed physicians to administer biologics for orthopedics, wound care, and pain management.
The audit is complimentary, but it's not for everyone. If you recognize yourself in the right column, request one. If you're on the left, this won't fit — and that's fine.
It is. The catch is qualification — we run about 8 audits per month and the application exists so we spend time with clinics that have a real shot at $50K/mo in new revenue. You keep the written revenue map either way.
Most agencies bolt AI marketing onto whatever offer you already have. We do the opposite: redesign the offer first (biologics + protocols + diagnostic front-end), then layer AI patient acquisition on top. AI applied to a commoditized offer just lights money on fire faster.
We've installed inside orthopedics, pain management, aesthetics/med spa, hair restoration, functional medicine, wound care, and sports medicine. If you're a licensed medical practice and patients come to you for outcomes, there's almost certainly a regenerative line that fits.
The federal pathway is FDA 361 HCT/P. Several states have explicit frameworks on top — Utah and Florida HB 1617 are the clearest. Your audit includes a written review of your specific jurisdiction.
We share specifics on the audit call — they vary by vertical, protocols, and marketing scope. The framework is simple: the cost should pay back inside the first 60–90 days of new regen revenue. If it doesn't, we wouldn't be pitching you.
Standard horizon is 90 days to $50K/mo in new monthly revenue. First treatments typically happen within 30–45 days of go-live. Anyone promising faster is selling, not operating.
One application, six minutes. A structured look at where regenerative medicine and AI patient acquisition install inside your clinic — and what the next 90 days could realistically deliver.
Start My ApplicationComplimentary · Qualified U.S. Clinics · ~8 Slots / Month